Related Experiment Video
Updated: Aug 16, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Ulcerative colitis in children: medical management
David A Gremse1, Karen D Crissinger
1Division of Pediatric Gastroenterology and Nutrition, University of South Alabama College of Medicine, #5321, 1504 Springhill Avenue, Mobile, AL 36604, USA. dgremse@usouthal.edu
Insights
Ulcerative colitis is a chronic inflammatory bowel disease affecting the colon. Treatment focuses on managing symptoms and preventing relapses using medications or surgery, while considering growth and development in pediatric patients.
Area of Science:
- Gastroenterology
- Pediatric Gastroenterology
- Immunology
Background:
- Ulcerative colitis (UC) is a chronic, relapsing inflammatory disorder of the colonic mucosa with unknown etiology.
- The inflammation typically affects a continuous segment of the bowel, starting in the rectum.
- Management aims to control symptoms and prevent disease flares due to the unknown cause.
Purpose of the Study:
- To review current therapeutic strategies for ulcerative colitis, particularly in pediatric patients.
- To discuss the role of various immunomodulators in managing pediatric ulcerative colitis.
- To highlight the comprehensive care needs of children with UC, including growth and development.
Main Methods:
- Review of existing literature on ulcerative colitis treatment.
- Analysis of therapeutic agents including 5-aminosalicylates, corticosteroids, and various immunomodulators.
- Consideration of surgical interventions like colectomy for refractory cases.
Main Results:
- 5-aminosalicylates and corticosteroids are primary treatments for ulcerative colitis.
- Immunomodulators (mercaptopurine, azathioprine, methotrexate, cyclosporine, tacrolimus) are increasingly used in pediatric UC.
- Colectomy is reserved for severe cases unresponsive to medical management.
Conclusions:
- Therapeutic strategies for ulcerative colitis focus on modulating inflammation to control symptoms and prevent relapses.
- Pediatric ulcerative colitis management requires balancing symptom control, growth, and development against treatment risks.
- The decision between long-term medical therapy and surgery involves careful risk-benefit assessment for children and adolescents.
Abstract:
Ulcerative colitis is a chronic relapsing inflammatory disorder of the colonic mucosa of unknown etiology. The inflammatory process involves the mucosa and submucosa in a continuous segment of bowel with rectal involvement in almost all cases. Since its etiology is unknown, therapy is directed at modulating the inflammatory response in order to control symptoms and to prevent relapses. 5-aminosalicylates and corticosteroids have been the most widely used therapeutic agents for treatment of ulcerative colitis. Recently, experience has been gained with the use of other immunomodulators, such as mercaptopurine, azathioprine, methotrexate, cyclosporine, and tacrolimus, in pediatric patients. Colectomy is indicated in patients with severe colitis who do not respond to intensive medical therapy. The care of children with ulcerative colitis not only involves control of symptoms from gastrointestinal and extraintestinal manifestations, but also optimizing growth and development. The complications of chronic inflammation and long-term medical therapy must be weighed against the risks and benefits of surgery for children and adolescents with this condition.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

